Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China · Delayed Price · Currency is CNY 31.88
+1.11 (3.61%)
At close: Mar 27, 2026
SHA:600645 Market Cap
SHA:600645 has a market cap or net worth of 14.53 billion as of March 27, 2026. Its market cap has increased by 53.86% in one year.
Market Cap
14.53B
Enterprise Value
12.99B
Revenue
1.47B
Ranking
n/a
PE Ratio
191.10
Stock Price
31.88
Market Cap Chart
Since May 9, 2006, SHA:600645's market cap has increased from 610.06M to 14.53B, an increase of 2,282.37%. That is a compound annual growth rate of 17.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 14.53B | 26.51% |
| Dec 31, 2025 | 11.49B | 30.57% |
| Dec 31, 2024 | 8.80B | -7.24% |
| Dec 29, 2023 | 9.49B | 19.17% |
| Dec 30, 2022 | 7.96B | -32.61% |
| Dec 31, 2021 | 11.81B | 28.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inner Mongolia Furui Medical Science | 15.46B |
| Anhui Anke Biotechnology (Group) | 15.42B |
| Jinyu Bio-technology | 15.25B |
| Mabwell (Shanghai) Bioscience | 14.51B |
| Staidson (Beijing) BioPharmaceuticals | 13.26B |
| Tibet Cheezheng Tibetan Medicine | 13.02B |
| Chengzhi | 12.65B |
| Pacific Shuanglin Bio-pharmacy | 12.47B |